Class II · ModerateActive recall
Wegovy
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Where it was soldNationwide within the United States.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Presence of Particulate Matter: Hair was found in a prefilled syringe
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byNovo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536
| Brand name | WEGOVY |
| Generic name | SEMAGLUTIDE |
| Active ingredient(s) | SEMAGLUTIDE |
| Distributed by / for | Novo Nordisk Inc. |
| NDC | 0169-4505-14 |
Show the full FDA record
| Full product label | Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14 |
| Recalling firm | Novo Nordisk Inc. |
| Distribution | Nationwide within the United States. |
| Quantity | N/A |
| Recall initiated | 2025-12-19 |
| Report date | 2026-01-07 |
| Recall completed | — |
| Recall number | D-0244-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Plainsboro NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.